BioRestorative Therapies, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -410.9% | -401.6% | -197.3% |
| FY2022 | -128.5% | -128.5% | -80.5% |
| FY2023 | -104.1% | -104.1% | -82.6% |
| FY2024 | -105.3% | -105.3% | -73.1% |
| FY2025 | -3,992.2% | -3,992.2% | -349.1% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -410.9% | -401.6% | -197.3% |
| FY2022 | -128.5% | -128.5% | -80.5% |
| FY2023 | -104.1% | -104.1% | -82.6% |
| FY2024 | -105.3% | -105.3% | -73.1% |
| FY2025 | -3,992.2% | -3,992.2% | -349.1% |